🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Ischemic Heart Failure

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI NCT07149714NA1 site📍 Moscow National Medical Research Center for Cardiology, Ministry o… · Tests: iVAC 2L Clinical Outcomes of Cardiovascular Disease NCT06459934n/a1 site📍 Ürümqi Xinjiang Medical University Common Femoral Vein-to-Artery Diameter Ratio for Detection of Elevated LVEDP NCT07866859n/a1 site📍 Chon Buri Burapha University · Tests: Ultrasound Measurement of Common Femoral Vein-to-Artery Diameter Ratio Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL) NCT07269366NA1 site📍 Groningen University Medical Center Groningen · Tests: CABG, PCI The Cardio-Metabolic Clinic NCT06203860NA1 site📍 Svendborg Odense University Hospital · Tests: Cardio-Metabolic Clinic China Extracorporeal Life Support Registry NCT04158479n/a1 site📍 Beijing Beijing Anzhen Hospital · Tests: ECMO STICH-3.0 International Trial Consortium NCT05761067NA1 site📍 Gothenburg Vastra Gotaland Region · Tests: Percutaneous Coronary Intervention (PCI) Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II NCT06271577NA4 sites📍 Rochester📍 Murray📍 Leeds AliveCor · Tests: AliveCor 12-lead ECG Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) NCT05485961Phase 2, Phase 3566 sites📍 Decatur📍 Huntsville📍 Montgomery CSL Behring · Tests: CSL300, Placebo Clinical Efficacy and Safety of Left Bundle Branch Area Pacing Using Quantitative Guidance of Multimodal Data in the Treatment of Heart Failure NCT07814612NA1 site📍 Nanchang Second Affiliated Hospital of Nanchang University · Tests: Apply multimodal data fusion for quantitative guidance of left bundle branch region pacing, Conventional Biventricular … Reliability of Multiple-Repetition-Maximum Tests in Patients With Cardiovascular Disease or Risk Factors NCT06796582n/a1 site📍 München Technical University of Munich Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure NCT05353946NA1 site📍 Madrid Guillermo Galeote; MD, PhD · Tests: Percutaneous coronary intervention (PCI) Naples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry) NCT06162247n/a1 site📍 Naples Federico II University Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE NCT07515508n/a4 sites📍 Bad Krozingen📍 Freiburg im Breisgau📍 Nuremberg University Heart Center Freiburg - Bad Krozingen Diffusion MRI in Heart Failure NCT02973633EARLY Phase 11 site📍 Charlestown Massachusetts General Hospital · Tests: Diffusion Tensor MRI (DTI), Gadolinium DOTA Meglumine Impact of COVID19 Outbreak in Cardiac Acute Care NCT04344912n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Data collection Heart Attack Blood Oxygen Therapy Trial NCT06662890NA1 site📍 Clydebank NHS National Waiting Times Centre Board · Tests: Supersaturated oxygen, Sham (No Treatment) AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor NCT06699056n/a8 sites📍 Orange📍 Pasadena📍 Detroit Peerbridge Health, Inc · Tests: 15-minutes of sitting during COR ECG Acquistion A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure NCT07265349Phase 1, Phase 24 sites📍 Shanghai📍 Shanghai📍 Shanghai Tasly Pharmaceutical Group Co., Ltd · Tests: Mesenchymal stem cells(HucMSCs), CABG Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions NCT07617376Phase 41 site📍 Wroclaw Wroclaw Medical University · Tests: Influenza vaccination Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure NCT07527156Phase 41 site📍 Prague Institute for Clinical and Experimental Medicine · Tests: Ketone Monoester (KE) CytOSorb TreatMent Of Critically Ill PatientS Registry NCT05146336n/a28 sites📍 Klagenfurt📍 Vienna📍 Aachen CytoSorbents, Inc · Tests: CytoSorb AI-Powered Electrocardiography for Diagnosis and Prognostic Prediction in Cardiovascular Disease (AI-CVD): Multicenter Retrospective Study NCT07856472n/a1 site📍 Incheon Inha University Hospital · Tests: Retrospective ECG Data Analysis Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock NCT04184635NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: VA-ECMO CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction NCT06258447NA5 sites📍 Clearwater📍 Atlanta📍 Detroit BioCardia, Inc. · Tests: Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy system Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging NCT03581318n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence NCT05972070n/a1 site📍 Brookfield ROM Technologies, INC · Tests: ROMTech Portable Connect Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock NCT04020263Phase 328 sites📍 Strasbourg📍 Marseille📍 Caen Pr Bruno LEVY · Tests: Levosimendan 2.5 MG/ML Injectable Solution, Placebo PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy NCT07443696Phase 23 sites📍 Beijing📍 Beijing📍 Tianjin Sinotau Pharmaceutical Group · Tests: Fasting XTR003/¹⁸F-FDG PET myocardial metabolic imaging, Glucose-loaded ¹⁸F-FDG PET Myocardial Metabolic Imaging Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial NCT04982419Phase 2, Phase 33 sites📍 Pittsburgh📍 Dallas📍 Richmond VA Office of Research and Development · Tests: Remote ischemic preconditioning, Sham remote ischemic conditioning
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy